Physicochemical basis of the digestion and absorption of triacylglycerol

Designing Functional Foods: Measuring and Controlling Food Structure Breakdown and Nutrient Absorption

Volumn , Issue , 2009, Pages 94-125

  Lo, C M ^a   Tso, P ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; CHOLESTEROL; ENZYMES; GLYCEROL; LIPOSOMES; METABOLISM; PHOSPHOLIPIDS; PHYSIOLOGY;

BRUSH BORDER MEMBRANES; CLINICAL DISORDERS; DIGESTIVE ENZYMES; INTRACELLULAR METABOLISM; LIPID METABOLISMS; LIPID TRANSPORTERS; UNILAMELLAR VESICLE; VERY LOW DENSITY LIPOPROTEINS;

FATTY ACIDS;

EID: 84903222032     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9781845696603.1.94     Document Type: Chapter

References (248)

1. Dawson P.A., Rudel L.L. Intestinal cholesterol absorption. Curr Opin Lipidol 1999, 10:315.
2. Wang D.Q. New concepts of mechanisms of intestinal cholesterol absorption. Ann Hepatol 2003, 2:113.
3. Plosch T., Kosters A., Groen A.K., Kuipers F. The ABC of hepatic and cholesterol transport. Handb Exp Pharmacol 2005, 170:465.
4. Kannel W.B., Dawber T.R., Friedman G.D., et al. Risk factors in coronary heart disease. An evaluation of several serum lipids as predictors of CHD. Ann Intern Med 1964, 61:888.
5. Levy D., Kannel W.B. Cardiovascular risks: New insights from Framingham. Am Heart J 1988, 116:266.
6. Austin M.A. Plasma triglyceride and coronary heart disease. Arteriosclerosis Thrombosis 1991, 11:2.
7. Beynen A.C., Kritchevsky D. Nutritional Effects on Cholesterol Metabolism 1986, Voorthuizen, Transmodial.
8. Valenzuela A., Morgado N. Trans fatty acid isomers in human health and in the food industry. Biol Res 1999, 32:273.
9. Katan M.B. Trans fatty acids and plasma lipoproteins. Nutr Rev 2000, 58:188.
10. Babayan V.K. Medium chain triglycerides and structured lipids. Lipids 1987, 22:417.
11. Mascioli E.A., Babayan V.K., Bistrian B.R., Blackburn G.L. Novel triacylglycerols for special medical purposes. J Par Ent Nutr 1988, 12:127S.
12. Heird W.C., Grundy S.M., Hubbard V.S. Structured lipids and their use in clinical nutrition. Am J Clin Nutr 1986, 43:320.
13. Bell S.J., Bradley D., Forse R.A., Bistrian B. The new dietary fats in health and disease. J Am Diet Assoc 1997, 97:280.
14. Mu H., Porsgaard T. The metabolism of structured triglycerides. Prog Lipid Res 2005, 44:430.
15. Tso P., Lee T., Demichele S.J. Lymphatic absorption of structured triglycerides vs. physical mix in a rat model of fat malabsorption. Am J Physiol 1999, 277:G333.
16. Tso P., Lee T., Demichele S.J. Randomized structured triglycerides increase lymphatic absorption of tocopherol and retinol compared with the equivalent physical mixture in a rat model of fat malabsorption. J Nutr 2001, 131:2157.
17. Abrams C.K., Hamosh M., Lee T.C., et al. Gastric lipase: localization in the human stomach. Gastroenterology 1988, 95:1460.
18. Hamosh M., Scanlon J.W., Ganot D., et al. Fat digestion in the newborn: characterization of lipase in gastric aspirates of premature and term infants. J Clin Invest 1981, 67:838.
19. Liao T.H., Hamosh P., Hamosh M. Fat digestion by lingual lipase: mechanism of lipolysis in the stomach and upper small intestine. Pediatr Res 1984, 18:402.
20. Cohen M., Morgan R.G.H., Hofmann A.F. Lipolytic activity of human gastric and duodenal juice against medium- and long-chain triglycerides. Gastroenterology 1971, 60:1.
21. Bodmer M.W., Angal S., Yarraton G.T., et al. Molecular cloning of a human gastric lipase and expression of the enzyme in yeast. Biochim Biophys Acta 1987, 909:237.
22. Grand R.J., Watkins J.B., Torti F.M. Development of the human gastrointestinal tract: a review. Gastroenterology 1976, 70:790.
23. Ross C.A.C. Fat absorption studies in the diagnosis and treatment of pancreatic fibrosis. Arch Dis Child 1955, 30:316.
24. Armand M., Hamosh M., Philpott J.R., et al. Gastric function in children with cystic fibrosis: effect of diet on gastric lipase levels and fat digestion. Pediatr Res 2004, 55:457.
25. Kelly K.A. Physiology of the Gastrointestinal Tract 1981, Raven Press, New York.
26. Senior J.R. Intestinal absorption of fats. J Lipid Res 1964, 5:495.
27. Carey M.C., Small D.M., Bliss C.M. Lipid digestion and absorption. Ann Rev Physiol 1983, 45:651.
28. Sarda L., Desnuelle P. Action de la lipase pancreatique sur les esters en emulsion. Biochim Biophys Acta 1958, 30:513.
29. Benzonana G., Desnuelle P. Etude cinetique de l'action de la lipase pancreatique sur des triglycerides en emulsion. Essai d'une enzymologie en milieu heterogene. Biochim Biophys Acta 1965, 105:121.
30. Desnuelle P. Lipid Absorption: Biochemical and Clinical Aspects 1976, MTP Press, Lancaster.
31. SchÖNheyder F., Volquartz K. Gastric lipase in man. Acta Physiol Scand 1946, 11:349.
32. Brockerhoff H. Substrate specificity of pancreatic lipase. Biochim Biophys Acta 1968, 159:296.
33. Mattson F.H., Beck L.W. The specificity of pancreatic lipase on the primary hydroxyl groups of glycerides. J Biol Chem 1956, 219:735.
34. Simmonds W.J. Blood Lipids and Lipoproteins: Quantitation, Composition and Metabolism 1972, Wiley Interscience, New York.
35. Dimagno E.P., Go V.L., Summerskill W.H. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973, 288:813.
36. Borgstrom B. On the mechanism of the hydrolysis of glycerides by pancreatic lipase. Acta Chem Scand 1953, 7:557.
37. Mattson F.H., Volpenhein R.A. The digestion and absorption of triglycerides. J Biol Chem 1964, 239:2772.
38. Mattson F.H., Volpenhein R.A. Hydrolysis of primary and secondary esters of glycerol by pancreatic juice. J Lipid Res 1968, 9:79.
39. Borgstrom B. Influence of bile salt, pH, and time on the action of pancreatic lipase; physiological implications. J Lipid Res 1964, 5:522.
40. Hofmann A.F., Borgstrom B. Hydrolysis of long-chain monoglycerides in micellar solution by pancreatic lipase. Biochim Biophys Acta 1963, 70:317.
41. Morgan R.G.H., Barrowman J., Borgstrom B. The effect of sodium taurodeoxycholate and pH on the gel filtration behaviour of rat pancreatic protein and lipases. Biochim Biophys Acta 1969, 175:65.
42. Erlanson C., Borgstrom B. Purification and further characterization of colipase from porcine pancreas. Biochim Biophys Acta 1972, 271:400.
43. Sternby B., Borgstrom B. Purification and characterization of human pancreatic colipase. Biochim Biophys Acta 1979, 572:235.
44. Maylie M.F., Charles M., Gache C., Desnuelle P. Isolation and partial identification of a pancreatic colipase. Biochim Biophys Acta 1971, 229:286.
45. Maylie M.F., Charles M., Gache C., Desnuelle P. On porcine pancreatic colipase: large scale purification and some properties. Biochem Biophys Res Commun 1973, 52:291.
46. Erlanson-Albertsson C. Pancreatic colipase. Structural and physiological aspects. Biochim Biophys Acta 1992, 1125:1.
47. Patton J.S., Albertsson P.A., Erlanson C., Borgstrom B. Binding of porcine pancreatic lipase and colipase in the absence of substrate studies by two-phase partition and affinity chromatography. J Biol Chem 1978, 253:4195.
48. Allouche M., Castano S., Colin D., Desbat B., Kerfelec B. Structure and orientation of pancreatic colipase in a lipid environment: PM-IRRAS and Brewster angle microscopy studies. Biochemistry 2007, 46:15188.
49. Borgstrom B., Dahlqvist A., Lundh G., SjÖVall J. Studies of intestinal digestion and absorption in the human. J Clin Invest 1957, 36:1521.
50. Van Den Bosch H., Postema N.M., De Haas G.H., Van Deenen L.L.M. On the positional specificity of phospholipase A from pancreas. Biochim Biophys Acta 1965, 98:657.
51. De Haas G.H., Postema N.M., Nieuwenhuizen W., Van Deenen L.L.M. Purification and properties of phospholipase A from porcine pancreas. Biochim Biophys Acta 1968, 159:103.
52. 2 in rat pancreatic juice. Acta Chem Scand 1967, 21:2897.
53. Verheij H.M., Volwerk J.J., Jansen E.H., et al. Methylation of histidine-48 in pancreatic phospholipase A2. Role of histidine and calcium ion in the catalytic mechanism. Biochemistry 1980, 19:743.
54. 2. Biochem Cell Biol 1991, 69:722.
55. 2. Acta Chem Scand 1971, 25:577.
56. 2: isolation and specificity. J Supramol Structure 1973, 1:490.
57. 2 isoenzyme from porcine pancreas. Biochim Biophys Acta 1979, 580:411.
58. Nalbone G., Lairon D., Carbonnier-Augeire M., et al. Pancreatic phospholipase A2 hydrolysis of phosphatidylcholines in various physicochemical states. Biochim Biophys Acta 1980, 620:612.
59. Richmond B.L., Boileau A.C., Zheng S., Huggins K.W., Granholm N.A., Tso P., Hui D.Y. Compensatory phospholipids digestion is required for cholesterol absorption in pancreatic phospholipase A(2)-deficient mice. Gastroenterology 2001, 120:1193.
60. Mcintyre N. Lipid Absorption: Biochemical and Clinical Aspects 1976, MTP Press Ltd, London.
61. Albro P.W., Thomas R.O. Enzymatic hydrolysis of di-(2-ethylhexyl) phthalate by lipases. Biochim Biophys Acta 1973, 360:380.
62. Momsen W.E., Brockman H.L. Purification and characterization of cholesterol esterase from porcine pancreas. Biochim Biophys Acta 1977, 486:103.
63. Erlanson C. Purification, properties and substrate specificity of a carboxylesterase in pancreatic juice. Scand J Gastroenterology 1975, 10:401.
64. Lombardo D., Guy O., Figarella C. Purification and characterization of a carboxyl ester hydrolase from human pancreatic juice. Biochim Biophys Acta 1978, 527:142.
65. Meyer J.G. Lipolytic enzymes of the human pancreas. II. Purification and properties of cholesterol ester hydrolase. Biochim Biophys Acta 1989, 1002:89.
66. Hofmann A.F., Borgstrom B. Physico-chemical state of lipids in intestinal content during their digestion and absorption. Fed Proc 1962, 21:43.
67. Hofmann A.F., Borgstrom B. The intraluminal phase of fat digestion in man: The lipid content of the micellar and oil phases of intestinal content obtained during fat digestion and absorption. J Clin Invest 1964, 43:247.
68. Dietschy J.M., Sallee V.L., Wilson F.A. Unstirred water layers and absorption across the intestinal mucosa. Gastroenterology 1971, 61:932.
69. Wilson F.A., Sallee V.L., Dietschy J.M. Unstirred water layers in intestine: rate determinant of fatty acid from micellar solutions. Science 1971, 174:1031.
70. Westergaard H., Dietschy J.M. The mechanism whereby bile acid micelles increase the rate of fatty acid and cholesterol uptake into the intestinal mucosal cell. J Clin Invest 1976, 58:97.
71. Watt S.M., Simmonds W.J. The specificity of bile salts in the intestinal absorption of micellar cholesterol in the rat. Clin Exp Pharmacol Physio 1976, 3:305.
72. Reynier M.O., Montet J.C., Gerolami A., et al. Comparative effects of cholic, chenodeoxycholic, and ursodeoxycholic acids on micellar solubilization and intestinal absorption of cholesterol. J Lipid Res 1981, 22:467.
73. Cohen B.I., Raicht R.F., Mosbach E.H. Sterol metabolism studies in the rat. Effects of primary bile acids (sodium taurochenodeoxycholate and sodium taurocholate) on sterol metabolism. J Lipid Res 1977, 18:223.
74. Watt S.M., Simmonds W.J. Effects of four taurine-conjugated bile acids on mucosal uptake and lymphatic absorption of cholesterol in the rat. J Lipid Res 1984, 25:448.
75. Sylven C. Influence of blood supply on lipid uptake from micellar solution by the rat small intestine. Biochim Biophys Acta 1970, 203:365.
76. Bhattacharyya A.K., Connor W.E. Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. J Clin Invest 1974, 53:1033.
77. Shulman R.S., Bhattacharyya A.K., Connor W.E., Fredrickson D.S. Beta-sitosterolemia and xanthomatosis. N Engl J Med 1976, 294:482.
78. Salen G., Shefer S., Nguyen L., et al. Sitosterolemia. Subcell Biochem 1997, 28:453.
79. Porter H.P., Saunders D.R. Isolation of the aqueous phase of human intestinal contents during the digestion of a fatty meal. Gastroenterology 1971, 60:997.
80. Patton J.S., Carey M.C. Watching fat digestion. Science 1979, 204:145.
81. Stafford R.J., Carey M.C. Physical-chemical nature of the aqueous lipids in intestinal content after a fatty meal: Revision of the Hofmann-Borgstrom Hypothesis. Clin Res 1981, 28:511.
82. Mansbach C.M., Newton D., Stevens R.D. Fat digestion in patients with bile acid malabsorption but minimal steatorrhea. Dig Dis Sci 1980, 25:353.
83. Porter H.P., Saunders D.R., Tytgat G., et al. Fat absorption in bile fistula man. A morphological and biochemical study. Gastroenterology 1971, 60:1008.
84. Woollett L.A., Wang Y., Buckley D.D., et al. Micellar solubilisation of cholesterol is essential for absorption in humans. Gut 2006, 55:197.
85. Thomson A.B.R., Keelan M., Garg M.L., Clandinin M.T. Intestinal aspects of lipid absorption: in review. Can J Physiol Pharmacol 1989, 67:179.
86. Strauss E.W. Electron microscopic study of intestinal fat absorption in vitro from mixed micelles containing linolenic acid, monoolein, and bile salt. J Lipid Res 1966, 7:307.
87. Chow S.L., Hollander D. A dual, concentration-dependent absorption mechanism of linoleic acid by rat jejunum in vitro. J Lipid Res 1979, 20:349.
88. Stremmel W. Uptake of fatty acids by jejunal mucosal cells is mediated by a fatty acid binding membrane protein. J Clin Invest 1988, 2001.
89. Stremmel W., Lotz G., Strohmeyer G., Berk P.D. Identification, isolation, and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes. J Clin Invest 1985, 75:1068.
90. Berk P.D., Wada H., Horio Y., et al. Plasma membrane fatty acid-binding protein and mitochondrial glutamic-oxaloacetic transaminase of rat liver are related. Proc Natl Acad Sci USA 1990, 87:3484.
91. Thurnhofer H., Hauser H. Uptake of cholesterol by small intestinal brush border membrane is protein-mediated. Biochemistry 1990, 29:2142.
92. Thurnhofer H., Schnabel J., Betz M., et al. Cholesterol-transfer protein located in the intestinal brush-border membrane. Partial purification and characterization. Biochim Biophys Acta 1991, 1064:275.
93. Thurnhofer H., Lipka G., Hauser H. Membrane proteins exposed on the external side of the intestinal brush-border membrane have fusogenic properties. Eur J Biochem 1991, 201:273.
94. Lipka G., Schulthess G., Thurnhofer H., et al. Characterization of lipid exchange proteins isolated from small intestinal brush border membrane. J Biol Chem 1995, 270:5917.
95. Wouters F.S., Markman M., Degraaf P., et al. The immunohistochemical localization of the non-specific lipid transfer protein (sterol carrier protein-2) in rat small intestine enterocytes. Biochim Biophys Acta 1995, 1259:192.
96. 2+-sensing protein. J Histochem Cytochem 1997, 45:383.
97. Farquhar M.G. The unfolding story of megalin (gp330): Now recognized as a drug receptor. J Clin Invest 1995, 96:1184.
98. Moestrup S.K., Cui S., Vorum H., et al. Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. J Clin Invest 1995, 96:1404.
99. Willnow T.E., Goldstein J.L., Orth K., et al. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J Biol Chem 1992, 267:26172.
100. Cui S., Verroust P.J., Moestrup S.K., Christensen E.I. Megalin/gp330 mediates uptake of albumin in renal proximal tubule. Am J Physiol 1996, 271:F900.
101. Willnow T.E., Hilpert J., Armstrong S.A., et al. Defective forebrain development in mice lacking gp330/megalin. Proc Natl Acad Sci USA 1996, 93:8460.
102. Hauser H., Dyer J.H., Nandy A., et al. Identification of a receptor mediating absorption of dietary cholesterol in the intestine. Biochemistry 1998, 37:17843.
103. Schulthess G., Compassi S., Werder M. Intestinal sterol absorption mediated by scavenger receptor is competitively inhibited by amphipathic peptides and proteins. Biochemistry 2000, 39:12623.
104. Van Bennekum A., Werder M., Thuahnai S.T. Class B scavenger receptor-mediated intestinal absorption of dietary beta-carotene and cholesterol. Biochemistry 2005, 44:4517.
105. Harmon C.M., Luce P., Beth A.H., Abrumad N.A. Labeling of adipocyte membranes by sulfo-N-succinimidyl derivatives of long-chain fatty acids: inhibition of fatty acid transport. J Membr Biol 1991, 121:261.
106. Abumrad N.A., El-Maghrabi M.R., Amri E.Z. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 1993, 268:17665.
107. Van Nieuwenhoven F.A., Verstijnen C.P.H.J., Abumrad N.A. Putative membrane fatty acid-translocase and cytoplasmic fatty acid-binding protein are co-expressed in rat heart and skeletal muscles. Biochem Biophys Res Commun 1995, 207:747.
108. Spitsberg V.L., Matitashivili E., Gorewit R.C. Association and coexpression of fatty-acid-binding protein and glycoprotein CD36 in bovine mammary gland. Eur J Biochem 1995, 230:872.
109. Poirier H., Degrace P., Niot I., et al. Localization and regulation of the putative membrane fatty-acid transporter (FAT) in the small intestine. Comparison with fatty acid-binding proteins (FABP). Eur J Biochem 1996, 238:368.
110. Abumrad N.A., Sfeir Z., Connelly M.A., Coburn C. Lipid transporters: membrane transport systems for cholesterol and fatty acids. Curr Opin Clin Nutr Metab Care 2000, 3:255.
111. Nauli A.M., Nassir F., Zheng S., et al. CD36 is important for chylomicron formation and secretion and may mediate cholesterol uptake in the proximal intestine. Gastroenterology 2006, 131:1197.
112. Schaffer J.E., Lodish H.F. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 1994, 79:427.
113. Stahl A., Hirsch D.J., Gimeno R.E., et al. Identification of the major intestinal fatty acid transport protein. Mol Cell 1999, 4:299.
114. Moulson C.L., Martin D.R., Lugus J.J., et al. Cloning of wrinkle-free, a previously uncharacterized mouse mutation, reveals crucial roles for fatty acid transport protein 4 in skin and hair development. Proc Natl Acad Sci USA 2003, 100:5274.
115. Herrmann T., Grone H.J., Langbein L., et al. Disturbed epidermal structure in mice with temporally controlled fatp4 deficiency. J Invest Dermatol 2005, 125:1228.
116. Hall A.M., Wiczer B.M., Herrmann T., et al. Enzymatic properties of purified murine fatty acid transport protein 4 and analysis of acyl-CoA synthetase in tissues from FATP4 null mice. J Biol Chem 2005, 280:11948.
117. Murata M., PerÄNen J., Schreiner R., et al. VIP21/caveolin is a cholesterol-binding protein. Proc Natl Acad Sci USA 1995, 92:10339.
118. 1 is concentrated in caveolae. J Histochem Cytochem 1994, 42:155.
119. Rothberg K.G., Ying Y.S., Kamen B.A., Anderson R.G.W. Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate. J Cell Biol 1990, 111:2931.
120. Ying Y.S., Anderson R.G.W., Rothberg K.G. Each caveola contains multiple glycosyl-phosphatidylinositol-anchored membrane proteins. Cold Spring Harb Symp Quant Biol 1992, 57:593.
121. Anderson R.G.W., Kamen B.A., Rothberg K.G., Lacey S.W. Potocytosis: sequestration and transport of small molecules by caveolae. Science 1992, 255:410.
122. Van Heek M., France C.F., Compton D.S., et al. In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the indentification of the active metabolites of SCH48461. J Pharmacol Exp Ther 1997, 283:157.
123. Van Heek M., Compton D.S., Davis H.R. The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys. Eur J Pharmacol 2001, 415:79.
124. Thurnhofer H., Hauser H. Uptake of cholesterol by small intestinal brush border membrane is protein-mediated. Biochemistry 1990, 29:2142.
125. Thurnhofer H., Schnabel J., Betz M., et al. Cholesterol-transfer protein located in the intestinal brush-border membrane. Partial purification and characterization. Biochim Biophys Acta 1991, 1064:275.
126. Berk P.D., Wada H., Horio Y., et al. Plasma membrane fatty acid-binding protein and mitochondrial glutamic-oxaloacetic transaminase of rat liver are related. Proc Natl Acad Sci 1980, 87:3484.
127. Wouters F.S., Markman M., Degraaf P., et al. The immunohistochemical localization of the non-specific lipid transfer protein (sterol carrier protein-2) in rat small intestine enterocytes. Biochim Biophys Acta 1995, 1259:192.
128. Schulthess G., Compassi S., Werder M., et al. Intestinal sterol absorption mediated by scavenger receptors is competitively inhibited by amphipathic peptides and proteins. Biochemistry 2000, 39:12623.
129. Van Heek M., Farley C., Compton D.S., et al. Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663. Br J Pharmacol 2000, 129:1748.
130. Altmann S.W., Davis H.R., Zhu L.J., et al. Niemann-Pick C1 like protein is critical for intestinal cholesterol absorption. Science 2004, 303:1201.
131. Davies J.P., Scott C., Oishi K., et al. Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia. J Biol Chem 2005, 280:12710.
132. Davis H.R., Zhu L.J., Hoos L.M., et al. Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J Biol Chem 2004, 279:33586.
133. Garcia-Calvo M., Lisnock J., Bull H.G., et al. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci USA 2005, 102:8132.
134. Iyer S.P., Yao X., Crona J.H., et al. Characterization of the putative native and recombinant rat sterol transporter Niemann-Pick C1 Like 1 (NPC1L1) protein. Biochim Biophys Acta 2005, 1722:282.
135. Knopfel M., Davies J.P., Duong P.T., Kvaerno L., Carreira E.M., Phillips M.C., Ioannou Y.A., Hauser H. Multiple plasma membrane receptors but not NPC1L1 mediate high-affinityy, ezetimibe-sensitive cholesterol uptake into the intestinal brush border membrane. Biochim Biophys Acta 2007, 1771:1140-1147.
136. Labonte E.D., Howles P.N., Granholm N.A., Rojas J.C., Davies J.P., Ioannou Y.A., Hui D.Y. Class B type I scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesicles. Biochim Biophys Acta 2007, 1771:1132.
137. Repa J.J., Turley S.D., Lobaccaro J.M.A., et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 2000, 289:1524.
138. Berge K.E., Tian H., Graf G.A., et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000, 290:1771.
139. Lee M.H., Lu K., Hazard S., et al. Identification of a gene ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 2001, 27:79.
140. Wang D.Q. Regulation of intestinal cholesterol absorption. Annu Rev Physiol 2007, 69:221.
141. Ockner R.K., Manning J.A. Fatty acid binding protein in small intestine. Identification, isolation and evidence for its role in cellular fatty acid transport. J Clin Invest 1974, 54:326.
142. Ockner R.K., Manning J.A., Poppenhausen R.B., Ho W.K. A binding protein for fatty acids in cytosol intestinal mucosa, liver, myocardium, and other tissues. Science 1972, 177:56.
143. Glatz J.F.C., Veerkamp J.H. Intracellular fatty acid-binding proteins. Int J Biochem 1985, 17:13.
144. Bass N.M. The cellular fatty acid-binding proteins: aspects of structure, regulation, and function. Int Rev Cytol 1988, 111:143.
145. Bansal M.P., Cook R.G., Danielson K.G., Medina D. A 14-kilodalton selenium-binding protein in mouse liver is fatty acid-binding protein. J Biol Chem 1989, 264:13780.
146. Cistola D.P., Sacchettini J.C., Banaszak L.J., et al. Fatty acid interactions with rat intestinal and liver fatty acid-binding proteins expressed in Escherichia coli. A comparative 13C NMR study. J Biol Chem 1989, 264:2700.
147. Storch J., Thumser A.F. The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta 2000, 1486:28.
148. Shaughnessy S., Smith E.R., Kodukula S., et al. Adipocyte metabolism in adipocyte fatty acid binding protein knockout mice (aP2-/-) after short-term high-fat feeding: functional compensation by the keratinocyte fatty acid binding protein. Diabetes 2000, 49:904.
149. Vassileva G., Huwyler L., Poirier K., Agellon L.B., Toth M.J. The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice. FASEB J 2000, 14:2040.
150. Agellon L.B., Toth M.J., Thomson A.B. Intracellular lipid binding proteins of the small intestine. Mol Cell Biochem 2002, 239:79.
151. Newberry E.P., Xie Y., Kennedy S.M., et al. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty-acid binding protein knockout mice. Hepatology 2006, 44:1191.
152. 2. J Biol Chem 1980, 255:4282.
153. Scallen T.J., Seetharam B., Srikantaiah M.V., et al. Sterol carrier protein hypothesis: requirement for three substrate-specific soluble proteins in liver cholesterol biosynthesis. Life Sci 1975, 16:853.
154. 1. J Biol Chem 1976, 251:5496.
155. Scallen T.J., Noland B.J., Gavey K.L., et al. Sterol carrier protein 2 and fatty acid-binding protein. J Biol Chem 1985, 260:4733.
156. 2) mediated transfer of cholesterol to mitochondrial inner membranes. Biochem Biophys Res Commun 1984, 122:509.
157. Leonard A.N., Cohen D.E. Submicellar bile salts stimulate phosphatidylcholine transfer activity of sterol carrier protein 2. J Lipid Res 1998, 39:1981.
158. Starodub O., Jolly C.A., Atshaves B.P., et al. Sterol carrier protein-2 localization in endoplasmic reticulum and role in phospholipid formation. Am J Physiol 2000, 279:C1259.
159. Murphy E.J. Sterol carrier protein-2 expression increases NBD-stearate uptake and cytoplasmic diffusion in L cells. Am J Physiol 1998, 275:G237.
160. Wirtz K.W., Wouters F.S., Bastiaens P.H., et al. The non-specific lipid transfer protein (sterol carrier protein 2) acts as a peroxisomal fatty acid-CoA binding protein. Biochem Soc Trans 1998, 26:374.
161. Dixit S.S., Sleat D.E., Stock A.M., Lobel P. Do mammalian NPC1 and NPC2 play a role in intestinal cholesterol absorption?. Biochem J 2007, 408:1.
162. Johnston J.M. Lipid Absorption: Biochemical and Clinical Aspects 1976, MTP Press, London.
163. Kuksis A., Manganaro F. Fat Absorption 1986, CRC Press, Boca Raton.
164. Rao G.A., Johnston J.M. Purification and properties of triglyceride synthetase from the intestinal mucosa. Biochim Biophys Acta 1966, 125:465.
165. Lehner R., Kukis A. Triacylglycerol synthesis by purified triacylglycerol synthetase of rat intestinal mucosa. Role of acyl-CoA acyltransferase. J Biol Chem 1995, 270:13630.
166. Smith S.J., Cases S., Jensen D.R., et al. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat Genet 2000, 25:87.
167. Oelkers P., Tinkelenberg A., Erdenize N., et al. A lecithin cholesterol acyltransferase-like gene mediates diacylglycerol esterification in yeast. J Biol Chem 2000, 275:15609.
168. Bell R.M., Ballas L.M., Coleman R.A. Lipid topogenesis. J Lipid Res 1981, 22:391.
169. Atkinson D., Small D.M. Recombinant lipoproteins: implications for structure and assembly of native lipoproteins. Annu Rev Biophys Biophys Chem 1986, 15:403.
170. Wetterau J.R., Zilversmit D.B. A triglyceride and cholesteryl ester transfer protein associated with liver microsomes. J Biol Chem 1984, 259:10863.
171. Wetterau J.R., Zilversmit D.B. Purification and characterization of microsomal triglyceride and cholesteryl ester transfer protein from bovine liver microsomes. Chem Phys Lipids 1985, 38:205.
172. Wetterau J.R., Zilversmit D.B. Localization of intracellular triacylglycerol and cholesteryl ester transfer activity in rat tissues. Biochim Biophys Acta 1986, 875:610.
173. Polheim D., David J.S.K., Schultz F.M., et al. Regulation of triglyceride biosynthesis in adipose and intestinal tissue. J Lipid Res 1973, 14:415.
174. Nilsson Ä. Intestinal absorption of lecithin and lysolecithin by lymph fistula rats. Biochim Biophys Acta 1968, 152:379.
175. Sato Y. The metabolic fate of lysolecithin administered into rat duodenal lumen. Tohuku J Exp Med 1970, 100:227.
176. Scow R.O., Stein Y., Stein O. Incorporation of dietary lecithin and lysolecithin into lymph chylomicrons in the rat. J Biol Chem 1967, 242:4919.
177. Subbaiah P.V., Sastry P.S., Ganguly J. Acylation of lysolecithin in the intestinal mucosa of rats. Biochem J 1970, 118:241.
178. Ottolenghi A. Estimation and subcellular distribution of lecithinase activity in rat intestinal mucosa. J Lipid Res 1964, 5:532.
179. Le Kim D., Betzing H. Intestinal absorption of polyunsaturated phosphatidylcholine in the rat. Hoppe-Seylers Z Physiol Chem 1976, 357:1321.
180. Erbland J.F., Marinetti G.V. The enzymatic acylation and hydrolysis of lysolecithin. Biochim Biophys Acta 1965, 106:128.
181. Spady D.K., Turley S.D., Dietschy J.M. Receptor-independent low density lipoprotein transport in the rat in vivo. Quantitation, characterization, and metabolic consequences. J Clin Invest 1985, 76:1113.
182. Turley S.D., Anderson J.M., Dietschy J.M. Rates of sterol synthesis and uptake in the major organs of the rat in vivo. J Lipid Res 1981, 22:551.
183. Anderson J.M., Turley S.D., Dietschy J.M. Relative rates of sterol synthesis in the liver and various extrahepatic tissues of normal and cholesterol-fed rabbits. Biochim Biophys Acta 1982, 711:421.
184. Spady D.K., Dietschy J.M. Sterol synthesis in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster, and rat. J Lipid Res 1983, 24:303.
185. Feldman E.B., Russell B.S., Chen R., et al. Dietary saturated fatty acid content affects lymph lipoproteins: studies in the rat. J Lipid Res 1983, 24:967.
186. Stange E.F., Dietschy J.M. The origin of cholesterol in the mesenteric lymph of the rat. J Lipid Res 1985, 26:175.
187. Pool C., Nutting D.F., Simmonds W.J., Tso P. Effect of Pluronic L-81, a hydrophobic surfactant, on intestinal mucosal cholesterol homeostasis. Am J Physiol 1991, 261:G256.
188. Dietschy J.M., Spady D.K., Stange E.F. Quantitative importance of different organs for cholesterol synthesis and low-density-lipoprotein degradation. Biochem Soc Trans 1983, 11:639.
189. Spady D.K., Bilheimer D.W., Dietschy J.M. Rates of receptor-dependent and -independent low density lipoprotein uptake in the hamster. Proc Natl Acad Sci USA 1983, 80:3499.
190. Thomson A.B.R., Dietschy J.M. Physiology of the Gastrointestinal Tract 1981, Raven Press, New York.
191. Clark S.B., Tercyak A.M. Reduced cholesterol transmucosal transport in rats with inhibited mucosal acyl CoA: cholesterol acyltransferase and normal pancreatic function. J Lipid Res 1984, 25:148.
192. Gallo L.L., Newbill T., Hyun J., Vahouny G.V. Role of pancreatic cholesterol esterase in the uptake and esterification of cholesterol by isolated intestinal cells. Proc Soc Exp Biol Med 1977, 156:277.
193. Borja C.R., Vahouny G.V., Treadwell C.R. Role of bile and pancreatic juice in cholesterol absorption and esterification. Am J Physiol 1964, 206:223.
194. Norum K.R., Helgerud P., Peterson L.B., et al. Influence of diets on acyl-CoA: cholesterol acyltransferase in villous and crypt cells from rat small intestinal mucosa and in the liver. Biochim Biophys Acta 1983, 751:153.
195. Norum K.R., Lilljeqvist A.C., Drevon D.A. Coenzyme-A-dependent esterification of cholesterol in intestinal mucosa from guinea-pig. Scand J Gastroenterol 1977, 12:281.
196. Field F.J., Cooper A.D., Erickson S.K. Regulation of rabbit intestinal acid acyl coenzyme A-cholesterol acyltransferase in vivo and in vitro. Gastroenterology 1982, 83:873.
197. Helgerud P., Saarem K., Norum K.R. Acyl-CoA:cholesterol acyltransferase in human small intestine: its activity and some properties of the enzymic reaction. J Lipid Res 1981, 22:271.
198. Gallo L.L., Chiang Y., Vahouny G.V., Treadwell C.R. Localization and origin of rat intestinal cholesterol esterase determined by immunocytochemistry. J Lipid Res 1980, 21:537.
199. Field F.J. Intestinal cholesterol esterase: intracellular enzyme or contamination of cytosol by pancreatic enzymes. J Lipid Res 1984, 25:389.
200. Bruneau N., Bendayan M., Gingras D., Ghitescu L., Levy E., Lombardo D. Circulating bile salt-dependent lipase originates from the pancreas via intestinal transcytosis. Gastroenterology 2003, 124:470-480.
201. Helgerud P., Haugen R., Norum K.R. The effect of feeding and fasting on the activity of acyl-CoA: cholesterol acyltransferase in rat small intestine. Eur J Clin Invest 1982, 12:493.
202. Watt S.M., Simmonds W.J. The effect of pancreatic diversion on lymphatic absorption and esterification of cholesterol in the rat. J Lipid Res 1981, 22:157.
203. Fukushima H., Aono S., Nakamura Y., et al. The effect of N-(alpha-methylbenzyl) linoleamide on cholesterol metabolism in rats. J Athero Res 1969, 10:403.
204. Harnett K.M., Walsh C.T., Zhang L. Effects of Bay o 2752, a hypocholesterolemic agent on intestinal taurocholate absorption and cholesterol esterification. J Pharmacol Exp Therap 1989, 251:502.
205. Tso P., Morshed K.M., Nutting D.F. Importance of acyl CoA-cholesterol acyltransferase (ACAT) in the esterification of cholesterol by enterocytes. FASEB J 1991, 5:A709.
206. Lee H.T., Roark W.H., Picard J.A., et al. Inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT) as hypocholesterolemic agents: synthesis and structure-activity relationships of novel series of sulfonamides, acylphosphonamides and acylphosphoramidates. Bioorg Med Chem Lett 1998, 8:289.
207. Chang C.C., Chen J., Thomas M.A., et al. Regulation and immunolocalization of acyl-coenzyme A:cholesterol acyltransferase in mammalian cells as studied with specific antibodies. J Biol Chem 1995, 270:29532.
208. Chang C.C., Sakashita N., Ornvold K., et al. Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine. J Biol Chem 2000, 275:28083.
209. Miyazaki A., Sakashita N., Lee O., et al. Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocyte-macrophages. Arterioscler Thromb Vas Biol 1998, 18:1568.
210. Buhman K.K., Accad M., Novak S., et al. Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT-2 deficient mice. Nat Med 2000, 6:1341.
211. Murphy S., Albright E., Mathur S.N., Field F.J. Effect of eicosapentaenoic acid on triacylglycerol transport in CaCo-2 cells. Biochim Biophys Acta 1990, 1045:147.
212. Kam N.T., Albright E., Mathur S.N., Field F.J. Inhibition of acylcoenzyme A:cholesterol acyltransferase activity in CaCo-2 cells results in intracellular triglyceride accumulation. J Lipid Res 1989, 30:371.
213. Kam N.T., Albright E., Mathur S.N., Field F.J. Effect of lovastatin on acyl-CoA: cholesterol acyltransferase (ACAT) activity and the basolateral-membrane secretion of newly synthesized lipids by CaCo-2 cells. Biochem J 1990, 272:427.
214. Traber M.G., Kayden H.J., Rindler M.J. Polarized secretion of newly synthesized lipoproteins by the CaCO-2 human intestinal cell line. J Lipid Res 1987, 28:1350.
215. Murphy S., Albright E., Mathur S.N., et al. Apolipoprotein B mRNA abundance is decreased by eicosapentaenoic acid in CaCo-2 cells. Effect on the synthesis and secretion of apolipoprotein B. Arterioscler Thromb 1992, 12:691.
216. Ockner R.K., Hughes F.B., Isselbacher K.J. Very low density lipoproteins in intestinal lymph: role in triglyceride and cholesterol transport during fat absorption. J Clin Invest 1969, 48:2367.
217. Ockner R.K., Manning J.A. Fatty acid binding protein in small intestine. Identification, isolation and evidence for its role in cellular fatty acid transport. J Clin Invest 1974, 54:326.
218. Tso P., Drake D.S., Black D.D., Sabesin S.M. Evidence for separate pathways of chylomicron and very low density lipoprotein assembly and transport by rat small intestine. Am J Physiol 1984, 247:G599.
219. Zilversmit D.B. The composition and structure of lymph chylomicrons in dog, rat, and man. J Clin Invest 1965, 44:1610.
220. Lindgren F.T., Jensen L.C., Hatch F.T. Blood, Lipids, and Lipoproteins: Quantitation, Composition and Metabolism 1972, Wiley, New York.
221. Mahley R.W., Bennett B.D., Morre D.J., et al. Lipoproteins associated with Golgi apparatus isolated from epithelial cells of rat small intestine. Lab Invest 1971, 25:435.
222. Vahouny G.V., Blendermann E.M., Gallo L.L., Treadwell C.R. Differential transport of cholesterol and oleic acid in lymph lipoproteins: sex differences in puromycin sensitivity. J Lipid Res 1980, 21:415.
223. Tso P., Balint J.A., Bishop M.B., Rodgers J.B. Acute inhibition of intestinal lipid transport by Pluronic L-81 in the rat. Am J Physiol 1981, 241:G487.
224. Tso P., Balint J.A., Rodgers J.B. Effect of hydrophobic surfactant (Pluronic L-81) on lymphatic lipid transport in the rat. Am J Physiol 1980, 239:G348.
225. Tso P., Drake D.S., Black D., Sabesin S.M. Evidence for separate pathways of chylomicrons and very-low density lipoprotein assembly and secretion by rat small intestine. Am J Physiol 1984, 247:G599.
226. Nutting D., Hall J., Barrowman J.A., Tso P. Further studies on the mechanism of inhibition of intestinal chylomicron transport by Pluronic L-81. Biochim Biophys Acta 1989, 1004:357.
227. Luchoomun J., Hussain M.M. Assembly and secretion of chylomicrons by differentiated cells: Nascent triglycerides and preformed phospholipids are preferentially used for lipoprotein assembly. J Biol Chem 1999, 274:19565.
228. Siddiqi S.A., Siddiqi S., Mahan J., Peggs K., Gorelick F.S., Mansbach C.M. The identification of a novel endoplasmic reticulum to Golgi SNARE complex used by the prechylomicron transport vesicle. J Biol Chem 2006, 281:20974.
229. Neeli I., Siddiqi S.A., Siddiqi S., Mahan J., Lagakos W.S., Binas B., Gheyi T., Storch J., Mansbach C.M. Liver fatty acid-binding protein initiates budding of pre-chylomicron transport vesicles from intestinal endoplasmic reticulum. J Biol Chem 2007, 282:17974.
230. Edge S.B., Hoeg J.M., Schneider P.D., Brewer H.B. Apolipoprotein B synthesis is humans: liver synthesizes only apolipoprotein B-100. Metabolism 1985, 34(726).
231. Glickman R.M., Rogers M., Glickman J.N. Apolipoprotein B synthesis by human liver and intestine in vitro. Proc Natl Acad Sci USA 1986, 83:5296.
232. Glickman R.M., Glickman J.N., Magun A., Brin M. Apolipoprotein synthesis in normal and abetalipoproteinemic intestinal mucosa. Gastroenterology 1991, 101:749.
233. Chen S.H., Habib G., Yang C.Y., et al. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 1987, 238(363).
234. Powell L.M., Wallis S.C., Pease R.J., et al. A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell 1987, 50:831.
235. Kane J.P., Hardman D.A., Paulus H.E. Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons. Proc Natl Acad Sci USA 1980, 77:2465.
236. Cardin A.D., Witt K.R., Barnhart C.L., Jackson R.L. Sulfhydryl chemistry and solubility properties of human plasma apolipoprotein B. Biochemistry 1982, 21:4503.
237. Martins I.J., Sainsbury A.J., Mamo J.C., Redgrave T.G. Lipid and apolipoprotein B-48 transport in mesenteric lymph and the effect of hyperphagia on the clearance of chylomicron-like emulsions in insulin-deficient rats. Diabetologia 1994, 37(238).
238. Hayashi H., Fujimoto K., Cardelli J.A., et al. Fat feeding increases size, but not number of chylomicrons produced by small intestine. Am J Physiol 1990, 259:G709.
239. Davidson N.O., Magun A.M., Brasitus T.A., Glickman R.M. Intestinal apolipoprotein A-I and B-48 metabolism: effects of sustained alterations in dietary triglyceride and mucosal cholesterol flux. J Lipid Res 1987, 28(388).
240. Isselbacher K.J., Scheig R., Plotkin G.R., Caulfield J.B. Congenital beta-lipoprotein deficiency: a hereditary disorder involving a defect in the absorption and transport of lipids. Medicine 1964, 43:347.
241. Ways P.O., Parmentier C.M., Kayden H.J., et al. Studies on the absorptive defect for triglyceride in abetalipoproteinemia. J Clin Invest 1967, 46:35.
242. Wetterau J.R., Aggerbeck L.P., Boume M.E., et al. Absense of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 1992, 256:999.
243. Gordon D.A., Jamil H. Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly. Biochim Biophys Acta 2000, 1486:72.
244. Sharp D., Ricci B., Kienzle B., et al. Human microsomal triglyceride transfer protein large subunit gene structure. Biochemistry 1994, 33:9057.
245. Ohashi K., Ishibashi S., Osuga J., et al. Novel mutations in the microsomal triglyceride transfer protein gene causing abetalipoproteinemia. J Lipid Res 2000, 41:1199.
246. Berriot-Varoqueaux N., Aggerbeck L.P., Samson-Bouma M., Wetterau J.R. The role of the microsomal triglyceride transfer protein in abetalipoproteinemia. Annu Rev Nutr 2000, 20:663.
247. Roy C.C., Levy E., Green P.H.R., Sniderman A., Letarte J., Buts J.P., et al. Malabsorption, hypocholesterolemia and fat filled enterocytes with increased intestinal apo B. Chylomicron retention disease. Gastroenterology 1987, 92:390.
248. Dannoura A.H., Berriot-Varoqueaux N., Amati P., et al. Anderson's disease: exclusion of apolipoprotein and intracellular lipid transport genes. Art Thromb Vasc Bio 1999, 19:2494.